A systematic review of the characteristics of adolescents with major depressive disorder in randomised controlled treatment trials

被引:1
|
作者
McCulloch, Amy [1 ,2 ]
Kroll, Leo [1 ]
Glass, James [3 ]
Dubicka, Bernadka [1 ,4 ]
机构
[1] Pennine Care NHS Fdn Trust Headquarters, Young Peoples Mental Hlth Res Unit, 225 Old St, Ashton Under Lyne OL6 75R, Lancs, England
[2] Northwest Boroughs Healthcare NHS Fdn Trust, Warrington CAMHS, 12 Birch Ave, Winwick WA2 9TN, England
[3] Pennine Care NHS Fdn Trust, Springleigh Clin, Hlth Young Minds Tameside & Glossop, Waterloo Rd, Stalybridge SK15 2AU, England
[4] Univ Manchester, Fac Biol Med & Hlth, Oxford Rd, Manchester M13 9PL, Lancs, England
关键词
Adolescent; Depression; Antidepressant; Psychological therapy; Randomised controlled trial; COGNITIVE-BEHAVIORAL THERAPY; ANTIDEPRESSANT EFFICACY TRIALS; EXCLUSION CRITERIA; RISK-FACTORS; PSYCHOTHERAPY; COMORBIDITY; CHILDHOOD; COMMUNITY; CHILDREN; IMPACT;
D O I
10.1016/j.ejpsy.2021.07.001
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Background and Objectives: Concerns exist around the generalizability of randomised controlled trials (RCTs) for adolescents with major depressive disorder (MDD). This review assesses whether adolescents with MDD treated in RCTs are representative of clinical samples. Methods: A systematic narrative review of selection criteria used in RCTs for adolescent MDD (PROSPERO CRD42018096298). Included were studies assessing psychological, pharmacological or combination treatments. Results: 52 studies were included. Overall, the reporting of selection criteria (defined as both inclusion and exclusion criteria), in the 23 psychotherapy trials was low (52% did not report on comorbid emotional disorders and 48% did not report on suicidal ideation). In contrast, the majority of selection criteria were reported in the 22 medication trials and the 7 combination trials. Where selection criteria were reported, most adolescents with comorbidities were excluded from psychotherapy and medication trials. The 7 combination trials included more adolescents with comorbidities. Of note, only 10 of the 52 studies reported on self-harm as a selection criteria. Conclusion: Reporting of the characteristics of depressed adolescents was poor in psychotherapy trials. Both psychotherapy and medication trials excluded many adolescents with co-morbid conditions, however combination trials tended to be more inclusive. There is concern that many RCTs for adolescent MDD may not be generalizable to clinical populations, particularly with regards to comorbidity, self-harm and suicidal ideation. The findings suggest that clinicians need to view the evidence base and guidelines developed from RCTs with discernment. Pragmatic trials are needed with representative clinical populations and comprehensive reporting of the selection criteria. (C) 2021 Asociacion Universitaria de Zaragoza para el Progreso de la Psiquiatria y la Salud Mental. Published by Elsevier Espana, S.L.U. All rights reserved.
引用
收藏
页码:1 / 10
页数:10
相关论文
共 50 条
  • [1] A systematic review of interventions for treatment resistant major depressive disorder in adolescents
    Boylan, Khrista
    MacQueen, Glenda
    Kirkpatrick, Ryan
    Lee, Jonathan
    Santaguida, Pasqualina L.
    EUROPEAN CHILD & ADOLESCENT PSYCHIATRY, 2020, 29 (04) : 433 - 443
  • [2] Prevalence of major depressive disorder in children and adolescents in China: A systematic review and meta-analysis
    Xu Dan-Dan
    Rao Wen-Wang
    Cao Xiao-Lan
    Wen Si-Ying
    Che Weng-Ian
    Chee, Ng H.
    Ungvari, Gabor S.
    Du Yasong
    Zhang Ling
    Xiang Yu-Tao
    JOURNAL OF AFFECTIVE DISORDERS, 2018, 241 : 592 - 598
  • [3] Economic evidence for the clinical management of major depressive disorder: a systematic review and quality appraisal of economic evaluations alongside randomised controlled trials
    Karyotaki, E.
    Tordrup, D.
    Buntrock, C.
    Bertollini, R.
    Cuijpers, P.
    EPIDEMIOLOGY AND PSYCHIATRIC SCIENCES, 2017, 26 (05) : 501 - 516
  • [4] Antidepressants for depressive disorder in children and adolescents: a database of randomised controlled trials
    Zhang, Yuqing
    Zhou, Xinyu
    Pu, Juncai
    Zhang, Hanping
    Yang, Lining
    Liu, Lanxiang
    Zhou, Chanjuan
    Yuan, Shuai
    Jiang, Xiaofeng
    Xie, Peng
    BMC PSYCHIATRY, 2018, 18
  • [5] The Potential of Scopolamine as an Antidepressant in Major Depressive Disorder: A Systematic Review of Randomized Controlled Trials
    Mocko, Pawel
    Sladowska, Katarzyna
    Kawalec, Pawel
    Babii, Yana
    Pilc, Andrzej
    BIOMEDICINES, 2023, 11 (10)
  • [6] A systematic review of interventions for treatment resistant major depressive disorder in adolescents
    Khrista Boylan
    Glenda MacQueen
    Ryan Kirkpatrick
    Jonathan Lee
    Pasqualina L. Santaguida
    European Child & Adolescent Psychiatry, 2020, 29 : 433 - 443
  • [7] Major depressive disorder in children and adolescents:: a review
    Bodur, Sahin
    Ueneri, Oezden Suekran
    ANADOLU PSIKIYATRI DERGISI-ANATOLIAN JOURNAL OF PSYCHIATRY, 2008, 9 (02): : 105 - 110
  • [8] The effect of bright light therapy on major depressive disorder: A systematic review and meta-analysis of randomised controlled trials
    Tong, Horace
    Dong, Na
    Lam, Charlene L. M.
    Lee, Tatia M. C.
    ASIAN JOURNAL OF PSYCHIATRY, 2024, 99
  • [9] Treating depression with physical activity in adolescents and young adults: a systematic review and meta-analysis of randomised controlled trials
    Bailey, A. P.
    Hetrick, S. E.
    Rosenbaum, S.
    Purcell, R.
    Parker, A. G.
    PSYCHOLOGICAL MEDICINE, 2018, 48 (07) : 1068 - 1083
  • [10] Antidepressants for depressive disorder in children and adolescents: a database of randomised controlled trials
    Yuqing Zhang
    Xinyu Zhou
    Juncai Pu
    Hanping Zhang
    Lining Yang
    Lanxiang Liu
    Chanjuan Zhou
    Shuai Yuan
    Xiaofeng Jiang
    Peng Xie
    BMC Psychiatry, 18